Category Archives: Healthcare

Oppenheimer Initiates a Buy Rating on Enanta Pharmaceuticals

Oppenheimer analyst Jay Olson initiated coverage with a Buy rating on Enanta Pharmaceuticals (NASDAQ: ENTA) today and set a price target of $135. The company’s shares opened today at $97.02, close to its 52-week high of $108. Olson wrote: “We

Thursday’s Midday Movers: Palatin Technologies (PTN), Anthera Pharmaceuticals (ANTH), Curis Inc (CRIS), SeaDrill LTD (SDRL), Cytosorbents Corp (CTSO)

So far Thursday, May 24, NASDAQ is down -0.52% and the S&P is down -0.04%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Palatin Technologies (AMEX:PTN), Anthera Pharmaceuticals (NASDAQ:ANTH), Curis Inc (NASDAQ:CRIS), SeaDrill

Nucana Plc Receives a Buy from Cowen & Co.

Cowen & Co. analyst Boris Peaker assigned a Buy rating to Nucana Plc (NASDAQ: NCNA) today. The company’s shares opened today at $27.25, close to its 52-week high of $30.41. According to TipRanks.com, Peaker is a 5-star analyst with an

A Director at Theravance Biopharma (NASDAQ: TBPH) is Buying Shares

Today, a Director at Theravance Biopharma (NASDAQ: TBPH), Burton Malkiel, bought shares of TBPH for $22.54K. This recent transaction increases Burton Malkiel’s holding in the company by 1.41% to a total of $1.65 million. In addition to Burton Malkiel, one

The Pres., Eur., M. East & Afr. of Zimmer Biomet Holdings is Exercising Options

Today, the Pres., Eur., M. East & Afr. of Zimmer Biomet Holdings, Katarzyna Mazur-Hofsaess, exercised options of Zimmer Biomet Holdings (NYSE: ZBH) for $995.8K. In addition to Katarzyna Mazur-Hofsaess, one other ZBH executive reported Sell trades in the last month.

A Director at SurModics is Exercising Options

Today, a Director at SurModics, Jose Bedoya, exercised options of SurModics (NASDAQ: SRDX) for $551.5K. See today’s analyst top recommended stocks >> Based on SurModics’ latest earnings report for the quarter ending March 31, the company posted quarterly revenue of